Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- 15 December 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 165, 12-18
- https://doi.org/10.1111/j.1365-2133.2011.10630.x
Abstract
Androgenetic alopecia affects both men and women. In men it produces male pattern hair loss with bitemporal recession and vertex baldness. In women it produces female pattern hair loss (FPHL) with diffuse alopecia over the mid‐frontal scalp. FPHL occurs as a result of nonuniform hair follicle miniaturization within follicular units. Diffuse alopecia is produced by a reduction in the number of terminal fibres per follicular unit. Baldness occurs only when all hairs within the follicular units are miniaturized and is a relatively late event in women. The concepts of follicular units and primary and secondary hair follicles within follicular units are well established in comparative mammalian studies, particularly in sheep. However, discovery of these structures in the human scalp hair and investigation of the changes in follicular unit anatomy during the development of androgenetic alopecia have provided a clearer understanding of the early stages of androgenetic alopecia and how the male and female patterns of hair loss are related. FPHL is the most common cause of alopecia in women and approximately one‐third of adult caucasian women experience hair loss. The impact of FPHL is predominantly psychological. While men anticipate age‐related hair loss, hair loss in women is usually unexpected and unwelcome at any age. Treatment options to arrest hair loss progression and stimulate partial hair regrowth for FPHL include the androgen receptor antagonists spironolactone and cyproterone acetate, the 5α‐reductase inhibitor finasteride and the androgen‐independent hair growth stimulator minoxidil. These treatments appear to work best when initiated early. Hair transplantation should be considered in advanced FPHL that is resistant to medical treatments. Hair transplantation requires well‐preserved hair growth over the occipital donor area. The psychological impact of FPHL may also be reduced by cosmetic products that improve the appearance of the hair. These agents work to minimize hair fibre breakage, improve hair volume or conceal visible bald scalp.This publication has 34 references indexed in Scilit:
- Quality of Life in Australian Women with Female Pattern Hair Loss~!2010-04-19~!2010-07-06~!2010-08-06~!The Open Dermatology Journal, 2010
- Female pattern hair loss in complete androgen insensitivity syndromeBritish Journal of Dermatology, 2010
- The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unitBritish Journal of Dermatology, 2008
- The role of scalp dermoscopy in the diagnosis of alopecia areata incognitaJournal of the American Academy of Dermatology, 2008
- Follicular miniaturization in female pattern hair loss: clinicopathological correlationsBritish Journal of Dermatology, 2006
- Evaluation and treatment of male and female pattern hair lossJournal of the American Academy of Dermatology, 2005
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJournal of the American Academy of Dermatology, 2004
- Hair transplanting: an important but often forgotten treatment for female pattern hair lossJournal of the American Academy of Dermatology, 2003
- Hormone Studies in Females with Androgenic HairlossGynecologic and Obstetric Investigation, 1991
- Patterned androgenic alopecia in womenJournal of the American Academy of Dermatology, 1988